Opioid-free vs. opioid-inclusive anaesthesia in laparoscopic cholecystectomy: a multicentre randomised controlled trial
In brief
Opioid-free anesthesia improves analgesia score by 1.3 points, below meaningful threshold
In 315 patients having laparoscopic gallbladder surgery, opioid-free anesthesia lowered the 24-hour analgesia score by 1.3 points, short of the 3-point difference considered clinically important. Pain with movement and pain at 90 days were similar, while nausea and vomiting and low blood pressure during surgery were less common. The findings do not support routine use, but leave open a role for selected patients.
- Journal
- Anaesthesia (Q1)
- Published
- 20 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Dan Wang, Liu Han, Yun Li, Jing-Hui Hu, Jiayu Jin, Wenya Guo, et al.
- PMID
- 43065122
- DOI
- 10.1111/anae.70462
Why clinicians should know about it
- Picked for Anesthesiology and Pain Medicine (paper of the day, 22 November 2026): Randomized trial of opioid-free anaesthesia, hypotension and PONV
Abstract
BACKGROUND: Laparoscopic cholecystectomy is the most common abdominal operation worldwide, yet whether opioid-free anaesthesia improves the overall analgesic benefit remains uncertain. METHODS: In this multicentre randomised controlled trial, adults undergoing elective laparoscopic cholecystectomy were randomised 1:1 to receive opioid-free anaesthesia (dexmedetomidine, esketamine and sevoflurane) or opioid-inclusive anaesthesia (sufentanil and sevoflurane). Patients received prophylactic anti-emetics and multimodal analgesia with flurbiprofen axetil and ropivacaine wound infiltration. The primary outcome was the overall benefit of analgesia score (0-28, lower scores indicate greater benefit) at 24 h postoperatively; a 3-point difference was considered clinically relevant. Secondary outcomes included pain on movement at 24 h and chronic postsurgical pain at 90 days. RESULTS: Between March and September 2025, 315 patients completed this trial (158 opioid-free, 157 opioid-inclusive). The mean (SD) 24-h overall benefit of analgesia score was 2.2 (2.4) after opioid-free anaesthesia vs 3.4 (3.1) after opioid-inclusive anaesthesia (adjusted mean difference -1.3; 95%CI -1.8 to -0.8, p < 0.001), without reaching the threshold for clinical importance. Incidence of pain on movement (adjusted mean difference -0.2; 95%CI -0.4-0) and chronic postsurgical pain (16.1% vs 15.5%; adjusted relative risk 1.03; 95%CI 0.55-1.91) did not differ between groups. Opioid-free anaesthesia was associated with reduced intra-operative hypotension (19.6% vs 35.7%; relative risk 0.55; 95%CI 0.37-0.80) and lower incidence of postoperative nausea and vomiting (23.4% vs 33.8%; relative risk 0.69; 95%CI 0.48-0.98). DISCUSSION: Opioid-free anaesthesia did not achieve a clinically meaningful improvement in overall benefit of analgesia. These findings do not support its routine adoption in laparoscopic cholecystectomy. However, the observed reductions in intra-operative hypotension and postoperative nausea and vomiting suggest that this regimen may warrant consideration in selected patients, pending validation in future trials.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.